Clinical Trial Update: Prospective Clinical Study of ZPR Regimen in Relapsed/Refractory Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 prospective clinical study of the ZPR regimen in relapsed/refractory diffuse large B-cell lymphoma is being reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• ZPR regimen

Snippet

Sponsor: Peng Liu | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: UNKNOWN